Results 191 to 194 of about 6,192 (194)

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin

European Journal of Clinical Pharmacology, 2007
exaly  

Vildagliptin protects endothelial cells against high glucose-induced damage

Biomedicine and Pharmacotherapy, 2018
exaly  

Vildagliptin

Reactions Weekly, 2015
openaire   +1 more source

P19-52 In silico and in vitro genotoxicity evaluation of vildagliptin impurities: vildagliptin cyclic amidine, vildagliptin diketopiperazine and vildagliptine amide

Toxicology Letters
M. Hamitoğlu, G. Tugcu, A.G. Kılıç, G. Esen, A. Aydın   +4 more
openaire   +1 more source